Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis

Head and Neck

Volumn 38, Issue 4, 2016, Pages 589-600

  De Almeida, John R ^a   Moskowitz, Alan J ^b   Miles, Brett A ^b   Goldstein, David P ^a   Teng, Marita S ^b   Sikora, Andrew G ^b   Gupta, Vishal ^b   Posner, Marshall ^b   Genden, Eric M ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

chemotherapy; cost utility; dominant; radiotherapy; transoral robotic surgery (TORS)

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; COMPARATIVE STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EARLY CANCER; HUMAN; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; ROBOT ASSISTED SURGERY; ADVERSE EFFECTS; CANCER STAGING; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; HEALTH CARE COST; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL NEOPLASMS; ROBOTIC SURGICAL PROCEDURE; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE;

CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; ROBOTIC SURGICAL PROCEDURES;

EID: 84934299758     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23930     Document Type: Article

References (43)

1. Genden EM, Kotz T, Tong CC, et al., Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope 2011; 121: 1668-1674.
2. Cohen MA, Weinstein GS, O'Malley BW Jr, Feldman M, Quon H,. Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck 2011; 33: 573-580.
3. White HN, Moore EJ, Rosenthal EL, et al., Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: One- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg 2010; 136: 1248-1252.
4. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H,. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136: 1079-1085.
5. Garden AS, Dong L, Morrison WH, et al., Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2013; 85: 941-947.
6. May JT, Rao N, Sabater RD, et al., Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma. Head Neck 2013; 35: 1796-1800.
7. Dziegielewski PT, Teknos TN, Durmus K, et al., Transoral robotic surgery for oropharyngeal cancer: Long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg 2013; 139: 1099-1108.
8. Moore EJ, Olsen SM, Laborde RR, et al., Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 2012; 87: 219-225.
9. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS,. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011; 137: 1112-1116.
10. Hurtuk AM, Marcinow A, Agrawal A, Old M, Teknos TN, Ozer E,. Quality-of-life outcomes in transoral robotic surgery. Otolaryngol Head Neck Surg 2012; 146: 68-73.
11. de Almeida JR, Byrd JK, Wu R, et al., A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review. Laryngoscope 2014; 124: 2096-2102.
12. Nichols AC, Yoo J, Hammond JA, et al., Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. trans-oral robotic surgery (ORATOR)-study protocol for a randomized phase II trial. BMC Cancer 2013; 13: 133.
13. Adelstein DJ, Ridge JA, Brizel DM, et al., Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012; 34: 1681-1703.
14. de Almeida JR, Villanueva NL, Moskowitz AJ, et al., Preferences and utilities for health states after treatment of oropharyngeal cancer: Transoral robotic surgery versus definitive (chemo)radiotherapy. Head Neck 2014; 36: 923-933.
15. Richmon JD, Quon H, Gourin CG,. The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery. Laryngoscope 2014; 124: 165-171.
16. Barbash GI, Glied SA,. New technology and health care costs-the case of robot-assisted surgery. N Engl J Med 2010; 363: 701-704.
17. Hodge CW, Bentzen SM, Wong G, et al., Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys 2007; 69: 1032-1041.
18. Spector ME, Chinn SB, Rosko AJ, et al., Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy? Laryngoscope 2012; 122: 1507-1511.
19. Life tables for the total population: United States 2008. Centers for Disease and Control website. Available at: Http://www.cdc.gov/nchs/data/dvs/LEWK3-2008.pdf. Accessed January 15, 2013.
20. Garden AS, Dong L, Morrison WH, et al., Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2013; 85: 941-947.
21. Physician Fee Schedule. Centers for Medicare & Medicaid Services website. Available at: Https://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx. Accessed January 15, 2013.
22. United States Department of Labor. Bureau of Labor and Statistics. BLS New Release: Usual Weekly Earnings of Wage and Salary Workers Fourth Quarter 2011. January 24, 2012. Available at: Http://www.bls.gov/news.release/pdf/wkyeng.pdf. Accessed September 24, 2012.
23. Lauzier S, Levesque P, Drolet M, et al., Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. J Clin Oncol 2011; 29: 4007-4013.
24. Pfister DG, Ang KK, Brizel D, et al., National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Head and Neck Cancers. 2011. Available at: Http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#head-and-neck. Accessed June 15, 2011.
25. United States Department of Labor. Bureau of Labor Statistics. Consumer Price Index (CPI Databases). January 2013. Available at: Http://www.bls.gov/cpi/data.htm. Accessed January 15, 2013.
26. Weinstein GS, O'Malley BW Jr, Magnuson JS, et al., Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope 2012; 122: 1701-1707.
27. Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG,. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 2010; 120: 2218-2222.
28. Galloway TJ, Turaka A, Ruth K, et al., Low rates of gastrostomy tube dependence in patients with T1-T2 oropharynx cancer treated without pharyngeal constrictor sparing. Int J Radiat Oncol Biol Phys 2011; 81 (Suppl 2): 2614.
29. Setton J, Caria N, Romanyshyn J, et al., Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: An update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2012; 82: 291-298.
30. Best SR, Ha PK, Blanco RG, et al., Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma. Head Neck 2011; 33: 1727-1734.
31. Caudell JJ, Schaner PE, Meredith RF, et al., Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009; 73: 410-415.
32. Monnier Y, Broome M, Betz M, Bouferrache K, Ozsahin M, Jaques B,. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: Incidence and risk factors. Otolaryngol Head Neck Surg 2011; 144: 726-732.
33. Clavel S, Nguyen DH, Fortin B, et al., Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 582-589.
34. Laupacis A, Feeny D, Detsky AS, Tugwell PX,. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473-481.
35. Bailey JG, Hayden JA, Davis PJ, Liu RY, Haardt D, Ellsmere J,. Robotic versus laparoscopic Roux-en-Y gastric bypass (RYGB) in obese adults ages 18 to 65 years: A systematic review and economic analysis. Surg Endosc 2014; 28: 414-426.
36. Keller DS, Senagore AJ, Lawrence JK, Champagne BJ, Delaney CP,. Comparative effectiveness of laparoscopic versus robot-assisted colorectal resection. Surg Endosc 2014; 28: 212-221.
37. Close A, Robertson C, Rushton S, et al., Comparative cost-effectiveness of robot-assisted standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of mend with localised prostate cancer: A health technology assessment from the perspective of the UK National Health Service. Eur Urol 2013; 64: 361-369.
38. Mmeje CO, Martin AD, Nunez-Nateras R, Parker AS, Thiel DD, Castle EP,. Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy. Curr Urol Rep 2013; 14: 26-31.
39. Ramsay C, Pickard R, Robertson C, et al., Systematic review and economic modeling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess 2012; 16: 1-313.
40. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB,. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253-1258.
41. White HN, Frederick J, Zimmerman T, Carroll WR, Magnuson JS,. Learning curve for transoral robotic surgery: A 4-year analysis. JAMA Otolaryngol Head Neck Surg 2013; 139: 564-567.
42. Cohen MA, Weinstein GS, O'Malley BW Jr, Feldman M, Quon H,. Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck 2011; 33: 573-580.
43. Quon H, Cohen MA, Montone KT, et al., Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 2013; 123: 635-640.